16649835

Source:http://linkedlifedata.com/resource/pubmed/id/16649835

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003469, umls-concept:C0008845, umls-concept:C0087111, umls-concept:C0439230, umls-concept:C1274040
pubmed:issue	3
pubmed:dateCreated	2006-5-2
pubmed:abstractText	Anxiety disorders are common in later life, but little is known about the long-term benefits and risks of pharmacotherapy.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/K23 MH 64196, http://linkedlifedata.com/resource/pubmed/grant/P30 MH 52247, http://linkedlifedata.com/resource/pubmed/grant/T32 MH8619986
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7801243
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Citalopram, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Uptake Inhibitors
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0160-6689
pubmed:author	pubmed-author:BlankStephenS, pubmed-author:DewMary AmandaMA, pubmed-author:HouckPatricia RPR, pubmed-author:KarpJordan FJF, pubmed-author:LenzeEric JEJ, pubmed-author:MillerMark DMD, pubmed-author:MulsantBenoit HBH, pubmed-author:PollockBruce GBG, pubmed-author:ReynoldsCharles FCF, pubmed-author:ShearM KatherineMK, pubmed-author:TraceyBarbaraB
pubmed:issnType	Print
pubmed:volume	67
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	468-72
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:16649835-Age Factors, pubmed-meshheading:16649835-Aged, pubmed-meshheading:16649835-Aged, 80 and over, pubmed-meshheading:16649835-Anxiety Disorders, pubmed-meshheading:16649835-Citalopram, pubmed-meshheading:16649835-Double-Blind Method, pubmed-meshheading:16649835-Female, pubmed-meshheading:16649835-Geriatric Assessment, pubmed-meshheading:16649835-Health Status, pubmed-meshheading:16649835-Humans, pubmed-meshheading:16649835-Male, pubmed-meshheading:16649835-Middle Aged, pubmed-meshheading:16649835-Placebos, pubmed-meshheading:16649835-Psychiatric Status Rating Scales, pubmed-meshheading:16649835-Quality of Life, pubmed-meshheading:16649835-Questionnaires, pubmed-meshheading:16649835-Serotonin Uptake Inhibitors, pubmed-meshheading:16649835-Sleep, pubmed-meshheading:16649835-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment.
pubmed:affiliation	Intervention Research Center for Late-Life Mood Disorders, the Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural